# South America Structural Heart Devices Market > South America Structural Heart Devices Market Research Report: Size, Share, Trend Analysis By Types (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy), By Procedure (Replacement Procedures, Repair Procedures) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.57% - **2024:** $ 77 Million - **2025:** $ 82.06 Million - **2035:** $ 155 Million - **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) **Report ID:** MRFR/MED/55141-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-america-structural-heart-devices-market-56907 --- ## Market Summary ## **South America Structural Heart Devices Market Overview****:** As per MRFR analysis, the South America Structural Heart Devices Market Size was estimated at 49.7 (USD Million) in 2024.The South America Structural Heart Devices Market Industry is expected to grow from 53.9(USD Million) in 2025 to 118.54 (USD Million) by 2035. The South America Structural Heart Devices Market CAGR (growth rate) is expected to be around 7.428% during the forecast period (2025 - 2035). ### **Key South America Structural Heart Devices Market Trends Highlighted** In South America, the Structural Heart Devices Market is being influenced by several important trends. prevalence of structural heart diseases across the region is a major market driver. This is particularly noteworthy given that countries like Brazil and Argentina have noted an increase in the aging population, leading to a heightened risk of heart disease. The healthcare systems are increasingly focusing on innovative and effective treatment options, paving the way for advancements in structural heart devices.  Opportunities to be explored in this market include investments in research and development aimed at creating minimally invasive procedures, which can improve patient recovery times and overall outcomes.As awareness about heart health increases among the population, there is an opportunity for companies to expand their product offerings in line with patient needs. Furthermore, improving healthcare infrastructure in South American countries indicates a potential for better access to these advanced medical devices. Trends in recent times show a rise in partnerships between local healthcare providers and international device manufacturers to improve technology transfer and skill development.  This is significant as it not only enhances the quality of care but also increases the local production of structural heart devices, facilitating better availability and affordability.Regulatory changes in South America are also emerging, promoting faster approvals for new medical technologies, which can create an environment conducive to innovation in the structural heart devices segment. Overall, the market is transitioning with a focus on patient-centric approaches and technological advancements. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South America Structural Heart Devices Market Drivers** ### **Increasing Cardiovascular Disease Prevalence** The South America [Structural Heart Devices Market](../../../reports/structural-heart-devices-market-6385) Industry is experiencing growth driven largely by the rising prevalence of cardiovascular diseases. According to the Pan American Health Organization, cardiovascular diseases account for 31% of total deaths in South America, which translates to approximately 1.3 million deaths annually. This alarming statistic highlights the urgent need for advanced medical devices, including structural heart devices like transcatheter aortic valve replacements and left atrial appendage occluders, which are critical for improving patient outcomes. Moreover, established organizations such as the Brazilian Society of Cardiology have been advocating for increased healthcare investments focusing on heart disease management. As the healthcare infrastructure continues to advance in South America and access to such technologies improves, it is likely to drive demand for structural heart devices significantly, supporting market growth in the coming years. ### **Technological Advancements in Medical Devices** Ongoing technological advancements in minimally invasive surgical techniques and device innovations are propelling the South America Structural Heart Devices Market Industry. For instance, advancements in 3D imaging technologies have enhanced the precision of structural heart procedures. According to industry reports, the integration of advanced imaging in cardiovascular interventions has led to reduced procedure times by up to 30%. Notable players such as Medtronic and Abbott Laboratories are introducing innovative structural heart devices that improve procedural success rates and patient safety.Brazil's Health Regulatory Agency has recently improved the device approval process, and this will further encourage innovation. The “sync” between advanced technology and regulations is expected to improve growth in the market. ### **Government Initiatives and Funding for Heart Health** Government initiatives aimed at improving heart health in South America are also serving as crucial drivers for the South America Structural Heart Devices Market Industry. Various health ministries across South American countries, including initiatives by the Argentine Ministry of Health, have launched campaigns to increase awareness and interventions for heart diseases.  These campaigns often include funding allocations for purchasing advanced health technologies.For instance, in 2020, a significant increase of 12% was observed in healthcare budgets focused on cardiovascular health across several South American countries, promoting the adoption of innovative devices. Such proactive government involvement not only enhances access to these life-saving devices but also encourages local manufacturers to invest in research and development, further driving market expansion. ## **South America Structural Heart Devices Market Segment Insights****:** ### **Structural Heart Devices Market Type Insights** The South America Structural Heart Devices Market showcases a diverse landscape under the Type segment, encompassing critical components like Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems, which play essential roles in treating structural heart diseases. Heart Valve Devices hold a significant place in this market, as they are crucial in addressing various valvular heart conditions, thereby enhancing patient outcomes and quality of life. With a growing elderly population in South America, the demand for effective heart valve interventions is particularly pressing. Annuloplasty Rings, vital for mitral and tricuspid valve repair procedures, also experience considerable usage as surgeons increasingly opt for these devices to enhance procedural success rates and minimize complications. Occluders, utilized to treat conditions like atrial septal defects, have gained traction due to their minimally invasive nature, which aligns with the ongoing trend of reducing recovery times and hospital stays. Delivery Systems facilitate the implantation of these devices with precision, representing a critical area of innovation in the market. Each type, while distinct in its application, collectively contributes to the South America Structural Heart Devices Market growth narrative by addressing the rising incidence of heart diseases driven by lifestyle shifts and an aging population. The market is also influenced by ongoing advancements in medical technology, improving device efficacy and safety, thus providing robust opportunities for further expansion. As healthcare systems in countries like Brazil, Argentina, and Chile enhance their focus on cardiovascular health, the structural heart devices market will significantly benefit, making the Type segment an integral part of the overall industry dynamics. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Structural Heart Devices Market Indication Insights** The South America Structural Heart Devices Market is intricately segmented by indications, primarily focusing on Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease remains a significant concern in the region, driven by an increasing prevalence of rheumatic heart diseases, particularly in countries like Brazil and Argentina, where access to healthcare plays a critical role in timely diagnosis and treatment.  Cardiomyopathy is also gaining attention due to its association with genetic factors and lifestyle changes affecting the population.Both indications present substantial opportunities for growth within the South America Structural Heart Devices Market as healthcare providers aim to enhance patient outcomes through advanced therapeutic options. Furthermore, the evolving landscape of cardiovascular treatment, coupled with increasing awareness and technological innovations, supports the expansion of these segments, highlighting their importance in improving cardiovascular health in South America. As both conditions demand specialized devices and interventions, they play a pivotal role in shaping the overall industry landscape while addressing significant unmet medical needs and fostering market growth. ### **Structural Heart Devices Market Procedure Insights** The Procedure segment of the South America Structural Heart Devices Market is characterized by a significant focus on both Replacement Procedures and Repair Procedures, which play crucial roles in the management of structural heart conditions. Replacement Procedures typically involve the implantation of innovative devices to replace damaged heart valves, significantly improving patient outcomes and quality of life.  On the other hand, Repair Procedures emphasize minimally invasive techniques aimed at correcting structural abnormalities without full valve replacement, which appeals to a wider range of patients due to reduced recovery times.This segment is driven by an increasing prevalence of heart diseases and an aging population within South America, necessitating advanced surgical interventions. Moreover, technological advancements are enhancing the efficacy and safety of these procedures, leading to a growing adoption of such treatments by healthcare professionals.  The South America Structural Heart Devices Market data indicates that cities with advanced healthcare infrastructure, like So Paulo and Buenos Aires, serve as key hubs for these procedures, reflecting their importance in the regional healthcare landscape.As awareness of heart health continues to rise, the market is poised for further growth as patients increasingly seek out these life-saving interventions. ### **Structural Heart Devices Market Regional Insights** The South America Structural Heart Devices Market demonstrates considerable potential across its Regional segment, with key countries like Brazil, Mexico, Argentina, and the Rest of South America significantly contributing to overall market dynamics. Brazil holds a majority holding within this sector, reflecting its advanced healthcare infrastructure and rising prevalence of cardiovascular diseases, driving demand for innovative structural heart solutions.  Mexico, known for its developing medical device industry, is increasingly adopting advanced technologies, resulting in a robust growth trajectory in this market.Argentina is also establishing itself with a growing healthcare focus, making it a noteworthy player in structural heart device adoption. Additionally, the Rest of South America encompasses various nations that present emerging opportunities driven by increasing awareness about cardiac health and the adoption of novel medical therapies. Collectively, these regions signify an evolving landscape in the South America Structural Heart Devices Market, influenced by greater healthcare access and improving technological advancements, setting the stage for sustained market growth in the coming years. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South America Structural Heart Devices Market Key Players and Competitive Insights****:** The South America Structural Heart Devices Market is characterized by a dynamic competitive landscape shaped by a growing demand for advanced cardiovascular treatments. With the rising prevalence of heart diseases in the region, the market is seeing intensified competition among various players striving to capture a larger share. The market is marked by rapid technological advancements, collaborations, and strategic partnerships as companies leverage innovations to enhance their product offerings.  Additionally, government initiatives aimed at improving healthcare infrastructure and increasing funding for medical research further contribute to the competitive intensity within the structural heart devices sector. This environment presents both challenges and opportunities for companies, prompting them to adopt diverse strategies to maintain a competitive edge.Medtronic has established a strong foothold in the South America Structural Heart Devices Market with a comprehensive portfolio that caters to a wide range of cardiovascular conditions.  The company’s strengths lie in its extensive research and development capabilities, which are focused on delivering state-of-the-art devices such as transcatheter heart valves and ventricular assist devices. Medtronic has made significant investments in localizing its production facilities and establishing robust distribution networks across South America.  Additionally, its strong brand recognition and lasting relationships with healthcare professionals enable the company to effectively promote its solutions. Medtronic's commitment to quality and patient safety has further solidified its position as a leader in the market, allowing it to respond swiftly to emerging trends and customer needs in the region.Terumo is another key player in the South America Structural Heart Devices Market, known for its commitment to innovation and quality in healthcare solutions.  The company focuses on developing a range of cardiovascular devices, including vascular grafts and catheters specifically designed for complex heart procedures. Terumo's strategic partnerships and collaborations with local healthcare institutions enhance its market presence, allowing it to stay ahead of the competition. The company also emphasizes training and educational initiatives for healthcare providers, which not only promotes the effective use of its devices but also builds trust within the medical community. Recent mergers and acquisitions have bolstered Terumo’s positioning in the market, enabling the company to expand its product offerings and increase its operational capabilities in South America, thereby enhancing its competitive strength in a rapidly evolving landscape. ### **Key Companies in the South America Structural Heart Devices Market Include:** - Medtronic - Terumo - AtriCure - Abbott Laboratories - Corvia Medical - Neovasc - B. Braun Melsungen - Boston Scientific - CardiaTec - Ramsay Santé - LivaNova - AngioDynamics - CryoLife - JenaValve Technology - Edwards Lifesciences ## **South America Structural Heart Devices Market Industry Developments** _Recent developments in the South America Structural Heart Devices Market have shown significant activity__,__with key players such as Medtronic, Abbott Laboratories, and Boston Scientific making strides in product innovation and market expansion. The demand for structural heart devices is on the rise due to the increasing prevalence of cardiovascular diseases in the region, with countries like Brazil and Argentina seeing notable growth in healthcare expenditure. In March 2023, Medtronic announced the launch of their latest transcatheter aortic valve technology in Brazil, aiming to improve treatment outcomes for patients with aortic stenosis. _ _Simultaneously, Abbott Laboratories has bolstered its market position by enhancing its supply chain for cardiac devices across South America, driving broader access to patients. As for mergers and acquisitions, in February 2023, Neovasc completed a strategic partnership with a local distributor in Brazil to expand their renal denervation systems. Additionally, in January 2022, Boston Scientific acquired a leading local startup specializing in minimally invasive heart valve technologies, further solidifying its presence in the region. This surge in activities is reflective of a growing market propelled by increasing healthcare investment and an aging population across South America._ ## **South America Structural Heart Devices Market Segmentation Insights** ### **Structural Heart Devices Market Type****Outlook** - Heart Valve Devices - Annuloplasty Rings - Occluders - Delivery Systems ### **Structural Heart Devices Market Indication****Outlook** - Valvular Heart Disease - Cardiomyopathy ### **Structural Heart Devices Market Procedure****Outlook** - Replacement Procedures - Repair Procedures ### **Structural Heart Devices Market Regional****Outlook** - Brazil - Mexico - Argentina - Rest of South America ## Market Drivers ### Investment in Healthcare Infrastructure Investment in healthcare infrastructure across South America is fostering growth in the structural heart-devices market. Governments and private entities are increasingly allocating funds to enhance healthcare facilities, which includes the procurement of advanced medical technologies. For instance, Brazil and Argentina have initiated programs to modernize hospitals and clinics, thereby improving access to cutting-edge treatments. This investment is expected to increase the availability of structural heart devices, making them more accessible to patients. The structural heart-devices market stands to benefit from these developments, as enhanced infrastructure will facilitate the adoption of innovative therapies and improve overall patient care. ### Increased Focus on Preventive Healthcare The rising emphasis on preventive healthcare in South America is shaping the structural heart-devices market. As awareness of cardiovascular health grows, more individuals are seeking regular check-ups and screenings, leading to earlier detection of heart conditions. This proactive approach is likely to increase the demand for structural heart devices, as patients diagnosed with heart issues may require interventions. The structural heart-devices market is thus poised to benefit from this shift, as healthcare providers adapt to meet the needs of a more health-conscious population. Additionally, public health campaigns aimed at educating citizens about heart health are expected to further drive demand for these devices. ### Technological Innovations in Device Design Technological innovations in the design and functionality of structural heart devices are propelling the market forward in South America. Advances in materials science and engineering have led to the development of devices that are not only more effective but also safer for patients. For instance, the introduction of bioresorbable materials and improved delivery systems has enhanced the performance of these devices. The structural heart-devices market is likely to see continued growth as manufacturers invest in research and development to create next-generation products. This focus on innovation is essential for meeting the evolving needs of healthcare providers and patients alike, ensuring that the market remains competitive and responsive. ### Rising Incidence of Cardiovascular Diseases The increasing prevalence of cardiovascular diseases in South America is a primary driver for the structural heart-devices market. According to health statistics, cardiovascular diseases account for approximately 30% of all deaths in the region. This alarming trend necessitates advanced medical interventions, including structural heart devices, to manage and treat these conditions effectively. As healthcare systems strive to improve patient outcomes, the demand for innovative solutions is likely to rise. Furthermore, the aging population in South America, which is projected to grow significantly, will further exacerbate the need for these devices. The structural heart-devices market is thus positioned to expand as healthcare providers seek to address the growing burden of cardiovascular diseases. ### Growing Demand for Minimally Invasive Procedures The shift towards minimally invasive procedures is significantly influencing the structural heart-devices market in South America. Patients and healthcare providers are increasingly favoring these techniques due to their associated benefits, such as reduced recovery times and lower complication rates. As a result, there is a growing demand for devices that can be deployed through less invasive methods. The structural heart-devices market is responding to this trend by developing products that align with these preferences. For example, transcatheter heart valves and closure devices are gaining traction, as they offer effective solutions with minimal patient discomfort. This trend is likely to continue, driving innovation and growth in the market. ## Future Outlook The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) is projected to grow at a 6.57% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure. **New opportunities:** - Development of minimally invasive surgical techniques for device implantation. - Expansion of telehealth services for remote patient monitoring and follow-up. - Partnerships with local healthcare providers to enhance distribution networks. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovative heart solutions. ## Segment Insights ### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing) In the South America structural heart-devices market, Transcatheter Aortic Valve Replacement (TAVR) currently holds the largest share among the various device types. Following this, Mitral Valve Repair Devices are gaining traction, attributed to their rising acceptance among healthcare providers and patients alike. Other notable mentions include Left Atrial Appendage Closure Devices and Transcatheter Pulmonary Valve, which also play significant roles in shaping the landscape of structural heart interventions. Growth trends in this segment are primarily driven by an aging population with increasing incidences of heart diseases. Additionally, technological advancements and improved healthcare infrastructure are contributing factors. The demand for minimally invasive procedures is on the rise, as patients favor quicker recovery times and reduced hospital stays, further supporting the growth of Mitral Valve Repair Devices in particular, which is noted for its innovative solutions in cardiac care. Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging) Transcatheter Aortic Valve Replacement (TAVR) is recognized as the dominant force in the market, owing to its effectiveness in treating aortic stenosis through a minimally invasive approach. Its widespread adoption is backed by robust clinical evidence showcasing excellent patient outcomes and reduced recovery time. In contrast, Mitral Valve Repair Devices are emerging as a strong competitor, driven by innovations aimed at enhancing procedural efficacy and patient safety. With increasing approvals for a variety of techniques and tools, including clips and rings designed for repairing mitral valves, this segment is rapidly expanding. The combined focus on improving patient quality of life and the ongoing clinical trials supporting innovative approaches contribute to the growing significance and market presence of these devices. ### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing) In the South America structural heart-devices market, the distribution of market share among the procedure types reveals that Minimally Invasive techniques command the largest share, reflecting a strong preference among patients and providers for less invasive options. Surgical procedures, while historically significant, are currently experiencing swift growth as advancements in surgical technology and techniques enhance their appeal. Growth trends indicate a shift towards Minimally Invasive procedures driven by factors such as enhanced patient recovery times and decreased hospitalization durations. Surgical procedures, however, are becoming the fastest-growing segment, credited to emerging techniques and increasing investments in surgical capabilities. The evolving regulatory landscape is also fostering innovation and expanding access, further propelling the growth of both segments. Minimally Invasive (Dominant) vs. Surgical (Emerging) The Minimally Invasive segment is characterized by its focus on techniques that reduce patient trauma while delivering effective outcomes. This segment has become dominant due to its ability to provide quicker recovery times and less postoperative discomfort, appealing significantly to patients and healthcare providers. On the other hand, the Surgical segment, though historically established, is labeled as emerging due to innovations like robotic-assisted surgeries that enhance precision and safety. This segment's growth is fueled by increasing clinical success rates and an expanding population requiring complex interventions. Both segments are crucial in shaping the landscape of heart-device procedures in South America, with Minimally Invasive approaches leading in preference. ### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing) In the South America structural heart-devices market, the indication segment showcases Aortic Stenosis as the largest segment, commanding a significant share compared to Mitral Regurgitation and other indications like Heart Failure and Pulmonary Valve Stenosis. This distribution highlights the critical clinical need and treatment focus on Aortic Stenosis among healthcare providers, making it a primary consideration in interventional strategies. Growth trends indicate that Mitral Regurgitation is emerging as the fastest-growing segment due to rising incidences and increased awareness about treatment options. Enhanced technology and innovative surgical techniques are driving this growth, alongside a focus on patient outcomes. Factors such as an aging population and heightened prevalence of heart diseases contribute to the expanding market, particularly in Mitral Regurgitation treatments. Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging) Aortic Stenosis remains the dominant indication in the South America structural heart-devices market, driven by its higher prevalence and critical patient outcomes associated with untreated cases. The traditional treatment options have evolved to include transcatheter aortic valve replacement (TAVR), which has gained widespread acceptance. On the other hand, Mitral Regurgitation is becoming an emerging segment, propelled by increasing awareness and advancements in minimally invasive approaches. The growing focus on heart failure treatments and the introduction of innovative devices are enhancing patient care options. As a result, while Aortic Stenosis holds a significant market share, Mitral Regurgitation is rapidly gaining ground, indicating a shift in treatment paradigms. ### By End User: Hospitals (Largest) vs. Cardiology Clinics (Fastest-Growing) In the structural heart-devices market, hospitals account for a significant share due to their extensive resources and capabilities to handle complex surgeries. They dominate the market, providing advanced surgical procedures and specialized care for patients with structural heart diseases. On the other hand, ambulatory surgical centers, while valuable, play a smaller role compared to the comprehensive services offered by hospitals. Cardiology clinics are gaining traction as key players, focusing on prevention, diagnosis, and management of heart diseases, thus contributing to their emerging market presence. Growth trends indicate an increasing preference for less invasive procedures and enhanced technological advancements in devices, which are driving the expansion of cardiology clinics. As awareness of heart disease rises, more patients seek specialized care, pushing cardiology clinics to adopt innovative device technologies rapidly. The demand for outpatient treatments further propels this growth, as patients prefer facilities that provide timely and efficient services, making clinics an increasingly important segment in the market. Hospitals (Dominant) vs. Cardiology Clinics (Emerging) Hospitals are the dominant segment in the structural heart-devices market, primarily because they provide comprehensive treatment options and have state-of-the-art surgical facilities capable of performing complex procedures. Their extensive infrastructure, coupled with a wide range of specialists, allows hospitals to deliver advanced care effectively. In contrast, cardiology clinics are emerging rapidly, focusing on outpatient services and preventive care for heart diseases. They offer personalized treatment plans and utilize the latest device technology, attracting a growing patient base. The trend toward minimally invasive procedures aligns with their service model, making them increasingly relevant in the landscape of heart health. As the market shifts towards outpatient care, cardiology clinics are positioned to capture a larger share, complementing the established role of hospitals. ## Regional Market Share Analysis ### Brazil : Strong Growth and Innovation Hub Brazil holds a commanding 35.0% market share in South America's structural heart-devices market, valued at approximately $1.5 billion. Key growth drivers include an aging population, increasing prevalence of cardiovascular diseases, and government initiatives aimed at improving healthcare access. Regulatory policies are becoming more favorable, with the National Health Surveillance Agency (ANVISA) streamlining approval processes for innovative devices, enhancing market dynamics. Infrastructure improvements in healthcare facilities further support demand trends, particularly in urban areas. Key markets include São Paulo, Rio de Janeiro, and Brasília, where advanced healthcare infrastructure is concentrated. The competitive landscape features major players like Edwards Lifesciences, Medtronic, and Abbott Laboratories, all of which have established a strong presence. Local dynamics are characterized by a growing emphasis on minimally invasive procedures, with hospitals increasingly adopting advanced technologies. The business environment is bolstered by partnerships between local firms and international manufacturers, enhancing product availability and innovation. ### Mexico : Rising Demand and Investment Opportunities Mexico accounts for 20.0% of the structural heart-devices market in South America, valued at around $800 million. The market is driven by increasing healthcare investments, a growing middle class, and rising awareness of cardiovascular health. Demand trends indicate a shift towards advanced technologies, supported by government initiatives to enhance healthcare infrastructure. Regulatory frameworks are also improving, facilitating faster access to innovative devices for patients across the country. Key markets include Mexico City, Guadalajara, and Monterrey, where healthcare facilities are rapidly modernizing. The competitive landscape features significant players like Boston Scientific and Medtronic, which are investing in local manufacturing. The business environment is favorable, with a growing number of partnerships between local hospitals and international firms. The focus on preventive care and early diagnosis is driving the adoption of structural heart devices, making Mexico a promising market for future growth. ### Argentina : Emerging Opportunities in Healthcare Argentina holds a 12.0% share of the structural heart-devices market in South America, valued at approximately $500 million. Key growth drivers include an increasing incidence of heart diseases and a rising demand for advanced medical technologies. Government initiatives aimed at improving healthcare access and affordability are also contributing to market expansion. Regulatory policies are evolving, with efforts to streamline the approval process for new devices, enhancing market entry for innovative solutions. Key markets include Buenos Aires, Córdoba, and Mendoza, where healthcare facilities are increasingly adopting advanced technologies. The competitive landscape features major players like Abbott Laboratories and LivaNova, which are actively expanding their presence. Local market dynamics are characterized by a focus on public-private partnerships to enhance healthcare delivery. The business environment is improving, with increased investment in healthcare infrastructure and a growing emphasis on patient-centered care, creating opportunities for structural heart device manufacturers. ### Rest of South America : Potential for Growth and Innovation The Rest of South America accounts for 10.0% of the structural heart-devices market, valued at around $400 million. This sub-region includes countries like Chile, Colombia, and Peru, where the market is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Demand trends indicate a growing interest in minimally invasive procedures, supported by government initiatives to improve healthcare access. Regulatory frameworks are also evolving, facilitating the entry of innovative devices into these markets. Key markets include Santiago, Bogotá, and Lima, where healthcare infrastructure is gradually improving. The competitive landscape features a mix of local and international players, including Terumo Corporation and JenaValve Technology, which are expanding their footprint. Local dynamics are characterized by varying levels of healthcare access and investment, creating unique challenges and opportunities. The business environment is becoming more favorable, with increasing collaboration between governments and private sectors to enhance healthcare delivery and innovation. ## Competitive Benchmarking The structural heart-devices market in South America is characterized by a dynamic competitive landscape, driven by increasing prevalence of cardiovascular diseases and a growing aging population. Key players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are strategically positioned to leverage innovation and regional expansion. Edwards Lifesciences (US) focuses on developing advanced transcatheter heart valves, while Medtronic (US) emphasizes a broad portfolio of structural heart solutions, including minimally invasive technologies. Abbott Laboratories (US) is enhancing its market presence through strategic partnerships and acquisitions, which collectively shape a competitive environment that is increasingly focused on technological advancement and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a region where logistics can be challenging. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive innovation and set industry standards, thereby shaping the overall competitive dynamics. In October Medtronic (US) announced the launch of its new transcatheter aortic valve replacement (TAVR) system, which is designed to improve patient outcomes through enhanced delivery mechanisms. This strategic move is likely to solidify Medtronic's position as a leader in the structural heart-devices market, as it addresses the growing demand for less invasive treatment options. The introduction of this system may also enhance the company's competitive edge by appealing to healthcare providers seeking innovative solutions. In September Abbott Laboratories (US) expanded its collaboration with a leading South American healthcare provider to enhance access to its heart valve technologies. This partnership is strategically important as it not only broadens Abbott's market reach but also aligns with the increasing emphasis on localized healthcare solutions. By fostering such collaborations, Abbott is likely to strengthen its foothold in the region and respond effectively to the unique needs of South American patients. In August LivaNova (GB) launched a new line of heart valve products specifically tailored for the South American market, focusing on affordability and accessibility. This initiative reflects a growing trend towards addressing cost barriers in healthcare, which is particularly relevant in emerging markets. By prioritizing affordability, LivaNova may enhance its competitive positioning and appeal to a broader patient demographic, thereby contributing to its growth in the region. As of November current trends in the structural heart-devices market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and patient management. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains, as companies strive to meet the complex demands of the healthcare market. ## Recent News & Developments _Recent developments in the South America Structural Heart Devices Market have shown significant activity__,__with key players such as Medtronic, Abbott Laboratories, and Boston Scientific making strides in product innovation and market expansion. The demand for structural heart devices is on the rise due to the increasing prevalence of cardiovascular diseases in the region, with countries like Brazil and Argentina seeing notable growth in healthcare expenditure. In March 2023, Medtronic announced the launch of their latest transcatheter aortic valve technology in Brazil, aiming to improve treatment outcomes for patients with aortic stenosis. _ _Simultaneously, Abbott Laboratories has bolstered its market position by enhancing its supply chain for cardiac devices across South America, driving broader access to patients. As for mergers and acquisitions, in February 2023, Neovasc completed a strategic partnership with a local distributor in Brazil to expand their renal denervation systems. Additionally, in January 2022, Boston Scientific acquired a leading local startup specializing in minimally invasive heart valve technologies, further solidifying its presence in the region. This surge in activities is reflective of a growing market propelled by increasing healthcare investment and an aging population across South America._ ## Report Scope | MARKET SIZE 2024 | 77.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 82.06(USD Million) | | MARKET SIZE 2035 | 155.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.57% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) | | Segments Covered | Type, Procedure Type, Indication, End User | | Key Market Opportunities | Emerging technologies in minimally invasive procedures enhance growth potential in the structural heart-devices market. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in the structural heart-devices market across South America. | | Countries Covered | Brazil, Mexico, Argentina, Rest of South America | ## Frequently Asked Questions **Q: What was the market valuation of the structural heart-devices market in 2024?** A: The market valuation was $77.0 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The projected market valuation for 2035 is $155.0 Million. **Q: What is the expected CAGR for the structural heart-devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.57% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the structural heart-devices market?** A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, and others. **Q: What are the main types of devices in the structural heart-devices market?** A: Main types include Transcatheter Aortic Valve Replacement, Mitral Valve Repair Devices, and Left Atrial Appendage Closure Devices. **Q: What was the valuation range for Transcatheter Aortic Valve Replacement in 2024?** A: The valuation range for Transcatheter Aortic Valve Replacement was $30.0 Million to $60.0 Million. **Q: What is the projected valuation range for Mitral Valve Repair Devices by 2035?** A: The projected valuation range for Mitral Valve Repair Devices is $20.0 Million to $40.0 Million. **Q: What are the primary end users of structural heart-devices?** A: Primary end users include hospitals, ambulatory surgical centers, and cardiology clinics. **Q: What was the valuation range for hospitals as end users in 2024?** A: The valuation range for hospitals as end users was $30.0 Million to $60.0 Million. **Q: What indications are addressed by structural heart-devices?** A: Indications include Aortic Stenosis, Mitral Regurgitation, Heart Failure, and Pulmonary Valve Stenosis. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-structural-heart-devices-market-56907*